Back to search
Non-Arteritic Anterior Ischemic Optic Neuropathy (NAION)
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Non-Arteritic Anterior Ischemic Optic Neuropathy (NAION) trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Non-Arteritic Anterior Ischemic Optic Neuropathy (NAION) trials you may qualify forGiant cell arteritis (GCA) is an inflammation of the blood vessels. A dangerous complication is sudden vision loss due to insufficient blood supply to the optic…
The goal of this clinical trial is to evaluate the safety and tolerability of a single dose of ER-100 in adults with optic nerve conditions, specifically Open A…
This trial will study the safety and efficacy of intravenous and sub-tenon delivery of cultured allogeneic adult umbilical cord derived mesenchymal stem cells f…
This is a phase 3, randomized, multicenter, vehicle-controlled, double-masked study to evaluate the efficacy and safety of intranasal cenegermin compared with v…
This study is designed for single-center, open-label, dose escalation phase I trial to evaluate the safety and tolerability of a single/multiple intravitreal in…
This series aims at studying the peripapillary and macular vascular changes in subjects with unilateral anterior ischemic optic neuropathy via Optical Coherence…